Literature DB >> 27569189

Correlation between mucin biology and tumor heterogeneity in lung cancer.

Menglin Xu1, Diane C Wang1, Xiangdong Wang2, Yong Zhang3.   

Abstract

Mucins (MUC) are a family consisting of large O-glycoproteins whose primary functions are to protect and lubricate cell epithelial surfaces and contribute to intra- and inter-cellular signal pathways, cell proliferation, growth and apotosis. With the development of new technologies, MUCs begin to be identified as an effective marker in evaluating the tumor heterogeneity in lung cancer. MUCs' diverse expressions in subtypes of lung cancer indicate the inter-tumor heterogeneity. MUCs' mutation may also contribute to the development of intra-heterogeneity and evolution of lung cancer. Understanding MUCs' association with lung cancer heterogeneity and its molecular regulatory mechanism will benefit the development of diagnosis, therapy choice, and prognosis prediction of lung cancer.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diagnosis; Lung cancer; MUC; Therapy; Tumor heterogeneity

Mesh:

Substances:

Year:  2016        PMID: 27569189     DOI: 10.1016/j.semcdb.2016.08.027

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  10 in total

1.  Requirement for MUC5AC in KRAS-dependent lung carcinogenesis.

Authors:  Alison K Bauer; Misha Umer; Vanessa L Richardson; Amber M Cumpian; Anna Q Harder; Nasim Khosravi; Zoulikha Azzegagh; Naoko M Hara; Camille Ehre; Maedeh Mohebnasab; Mauricio S Caetano; Daniel T Merrick; Adrie van Bokhoven; Ignacio I Wistuba; Humam Kadara; Burton F Dickey; Kalpana Velmurugan; Patrick R Mann; Xian Lu; Anna E Barón; Christopher M Evans; Seyed Javad Moghaddam
Journal:  JCI Insight       Date:  2018-08-09

2.  Roles of acyl-CoA synthetase long-chain family member 5 and colony stimulating factor 2 in inhibition of palmitic or stearic acids in lung cancer cell proliferation and metabolism.

Authors:  Linlin Zhang; Jiapei Lv; Chengshui Chen; Xiangdong Wang
Journal:  Cell Biol Toxicol       Date:  2020-04-28       Impact factor: 6.691

3.  Relationship between tumor size and metastatic site in patients with stage IV non-small cell lung cancer: A large SEER-based study.

Authors:  Qinge Shan; Yanling Fan; Jun Guo; Xiao Han; Haiyong Wang; Zhehai Wang
Journal:  PeerJ       Date:  2019-10-10       Impact factor: 2.984

4.  Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles.

Authors:  Bo Ling; Guangbin Ye; Qiuhua Zhao; Yan Jiang; Lingling Liang; Qianli Tang
Journal:  Front Mol Biosci       Date:  2021-01-11

5.  Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma.

Authors:  Shuye Lin; Cuimeng Tian; Jianhui Li; Bin Liu; Teng Ma; Keqiang Chen; Wanghua Gong; Ji Ming Wang; Jiaqiang Huang
Journal:  Oncol Rep       Date:  2021-03-31       Impact factor: 3.906

6.  YBX1 Enhances Metastasis and Stemness by Transcriptionally Regulating MUC1 in Lung Adenocarcinoma.

Authors:  Qiang Xie; Shilei Zhao; Wenzhi Liu; Yanwei Cui; Fengzhou Li; Zhuoshi Li; Tao Guo; Wendan Yu; Wei Guo; Wuguo Deng; Chundong Gu
Journal:  Front Oncol       Date:  2021-12-15       Impact factor: 6.244

7.  Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer.

Authors:  Ling Min; Ting Zhu; Bo Lv; Taixue An; Qichao Zhang; Yanyan Shang; Zhiwu Yu; Lei Zheng; Qian Wang
Journal:  Int J Clin Oncol       Date:  2022-04-28       Impact factor: 3.402

8.  Genomic profiling and the impact of MUC19 mutation in hepatoid adenocarcinoma of the stomach.

Authors:  Mengxuan Zhu; Erbao Chen; Shan Yu; Chen Xu; Yiyi Yu; Xin Cao; Wei Li; Pengfei Zhang; Yan Wang; Baofeng Lian; Shuirong Zhang; Yueting Qu; Lujia Huang; Weiwei Shi; Yuehong Cui; Li Qian; Tianshu Liu
Journal:  Cancer Commun (Lond)       Date:  2022-07-19

9.  Reliability of using circulating tumor cells for detecting epidermal growth factor receptor mutation status in advanced non-small-cell lung cancer patients: a meta-analysis and systematic review.

Authors:  Fang Hu; Xiaowei Mao; Yujun Zhang; Xiaoxuan Zheng; Ping Gu; Huimin Wang; Xueyan Zhang
Journal:  Onco Targets Ther       Date:  2018-03-14       Impact factor: 4.147

Review 10.  Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer.

Authors:  Yue Ning; Hongmei Zheng; Yuting Zhan; Sile Liu; Yang Yang; Hongjing Zang; Jiadi Luo; Qiuyuan Wen; Songqing Fan
Journal:  J Exp Clin Cancer Res       Date:  2020-08-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.